ArticleJournal of market access & health policy2026

Use of Real-World Evidence in Health Technology Assessments of Non-Oncology Rare Disease Therapies.

Oliver Blandy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.